Kimmtrak: Everything You Wanted to Know & More

Dr. Marlana Orloff is an assistant professor of medicine and medical oncologist at Thomas Jefferson University Hospital – Sidney Kimmel Cancer Center in Philadelphia, PA.

Her clinical and research focus is on primary and advanced melanomas. Her main interest is in rare melanomas including uveal , conjunctival, and mucosal melanoma. Her research is centered on investigating the epidemiology of uveal melanoma and discovery of novel therapies for primary and advanced uveal, conjunctival, mucosal and cutaneous melanoma. She works very closely with the team at Wills Eye Hospital to manage hundreds of patients with primary and metastatic ocular melanoma. She is a member of a multidisciplinary team of medical oncologists, interventional radiologists, radiation oncologist and numerous other essential personnel that treats patients with metastatic uveal melanoma from all over the country. She is principal and co-investigator on a number of clinical trials enrolling patients with primary and advanced melanomas of all types. Her current research is funded by Melanoma Research Alliance, industry support, and the generous philanthropic support of patients and their families.

Dr. Sara Selig is the Co-Founder and Director of the MRF’s CURE OM initiative. Sara initially became involved with the OM community when her husband, Gregg, was diagnosed with the disease in 2006, at the age of 34, when Sara was a fourth year medical student. At the time of Gregg’s diagnosis, Gregg and Sara became fierce advocates for Gregg’s care and the entire OM community as well. Sara continues to be a passionate advocate for the ocular melanoma field—working to accelerate research, promote collaboration, and support patients and caregivers through her leadership of the CURE OM initiative. She is currently Associate Physician in the Department of Internal Medicine, Division of Global Health Equity at Brigham and Women’s Hospital and an Instructor in Medicine at Harvard Medical School.